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Abstract
Psychosis is a multifactorial condition arising from an interaction between genetic liability
and exposure to environmental risk factors, in particular childhood trauma. Furthermore,
accumulating evidence supports a role for the immune system in the aetiology of psychosis.
Increased peripheral levels of pro-inflammatory cytokines and reduced neurotrophic factors
are found in patients with psychosis. Childhood trauma is highly prevalent in psychosis
patients and is also associated with increased pro-inflammatory cytokines and reduced neu-
rotrophic factors. Recent studies suggest the increase in pro-inflammatory cytokines and
decrease in neurotrophic factors seen in psychosis may be attributable to the effects of child
maltreatment. The aim of this study was to improve understanding of the relation between
childhood trauma, inflammation and psychosis. We examined separate and interaction
effects of psychosis liability and childhood trauma on serum levels of BDNF, CCL-2, CRP,
IFN-γ, IGFBP2, IL-6, PDGF, SCF and TNF-α in 40 patients with recent onset psychosis, 13
patients at Ultra-High Risk (UHR) for psychosis, 31 unaffected siblings of psychosis patients
and 41 healthy controls. Childhood trauma was assessed retrospectively with the Childhood
Trauma Questionnaire (CTQ). No statistically significant effects of psychosis liability or
childhood trauma on concentrations of cytokines or growth factors in peripheral blood were
found, nor were there any statistically significant interaction effects of psychosis liability with
childhood trauma on serum levels of cytokines and growth factors.
Introduction
Psychosis is a multifactorial condition arising from an interaction between genetic liability and
exposure to environmental risk factors[1]. The traditional biological explanatory model
includes neurodevelopmental abnormalities and dopamine dysregulation. In recent decades,
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this view has been expanded by a hypothesized role for the immune system in the aetiology of
psychosis. Counts and function of immune cells, including monocytes and T cells and serum
levels of cytokines were shown to be altered in the peripheral blood of psychosis patients [2].
While interleukin (IL)-12, interferon (IFN)-y, tumor necrosis factor (TNF)-α and soluble IL-2
receptor (sIL-2s) are elevated in both recent onset as well as chronic and medicated psychosis
patients, pro-inflammatory cytokines IL-1β, IL-6 and transforming growth factor (TGF)-β are
elevated only in patients with recent onset psychosis and acute relapse and normalized after
antipsychotic treatment [3]. A recent study on a large series of 180 antipsychotic-naive schizo-
phrenia patients from four different sites [4] confirmed abnormal levels of both pro- and anti-
inflammatory cytokines, which were also dependent on the duration and treatment of the dis-
ease. Immune dysregulation can affect brain function via several pathways [5,6]. For example,
some cytokines can pass the blood brain barrier and are neurotoxic or induce neuroinflamma-
tion [7]. Also, the immune system has a beneficial role in neurodevelopment and plasticity
which can be disturbed by both deficient and exaggerated immune activation [8]. Further-
more, the immune system is connected to other regulatory systems, e.g. the neuroendocrine
stress response, glutamate transmission and secretion of neurotrophic factors. Inflammation
has been linked to decreased brain-derived neurotrophic factor (BDNF) levels [9]. BDNF is a
growth factor essential for neurodevelopment and plasticity. Reduced BDNF levels have been
reported in schizophrenia [10]. It is still largely unknown whether altered levels of cytokines
and (neuro)trophic factors in psychosis are a cause or consequence of psychotic diseases or an
intermediate factor linking other risk factors to psychosis.
Childhood trauma was consistently shown to be associated with psychotic disorders in a
dose-response manner, across varying designs including large prospective studies [11]. Psy-
chosocial stress activates the hypothalamic-pituitary-adrenal axis, resulting in release of gluco-
corticoids. Glucocorticoid receptors are ubiquitously expressed in immune cells. The acute
effects of glucocorticoids are largely immunosuppressive [12,13]. However, prolonged stress
especially during critical time frames may affect the immune system differentially and result in
low grade inflammation [14]. Childhood maltreatment during the first decade of life was asso-
ciated with markers of inflammation in adults [15]. A dose-response relation was found
between severity of maltreatment and increased levels of high sensitive C-reactive protein
(CRP), fibrinogen and white blood cell count. In a population of medicated and chronic
patients with schizophrenia or schizoaffective disorder, IL-6 and TNF-α were significantly
raised in the subset of 24 out of 40 patients that reported a history of childhood trauma com-
pared to healthy and non-traumatized controls [16]. In the group of patients that did not
report childhood trauma, levels of pro-inflammatory cytokines were comparable to healthy
controls. In patients with recent onset psychosis, hsCRP levels were raised only in the sub-
group of patients who had experienced sexual abuse [17].
These studies suggest the increase in pro-inflammatory cytokines and decrease in neuro-
trophic factors seen in psychosis may be attributable to the effects of child maltreatment.
Another possibility is that individuals at (genetic) risk for psychosis are more vulnerable to
effects of child maltreatment on the immune system. It is still largely unknown how psychosis
liability and childhood trauma interact. Furthermore, only healthy controls and psychosis
patients, but not other psychosis liability groups have been examined.
The aim of this study was to improve understanding of the association between childhood
trauma, inflammation and psychosis. It concerns a secondary analysis of a previously
described study sample [18]. We examined serum levels of cytokines and growth factors,
namely BDNF, chemokine (C-C motif) ligand (CCL)-2, CRP, IFN-γ, insulin-like growth factor
binding protein (IGFBP2), IL-6, platelet-derived growth factor (PDGF), stem cell factor (SCF)
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and TNF-α in groups with different liability for psychosis, with and without the experiences of
childhood trauma.
Psychosis can be seen as the expression of a psychosis phenotype along a continuum
[19,20], ranging from individuals with increased risk to psychotic disorder, to individuals with
mild or nonspecific symptoms, to individuals with moderate, subthreshold symptoms and
functional decline, to people who have a single psychotic episode and finally severe and unre-
mitting psychotic illness [19]. In this study, four groups along this psychosis continuum were
selected: patients with recent-onset psychotic disorder, patients with moderate, subthreshold
psychotic symptoms (so-called ultra-high risk for psychosis), unaffected siblings of patients
with psychotic disorder and healthy controls. Furthermore, (interaction) effects of lower vs.
higher psychosis liability and childhood trauma on serum levels of cytokines and growth fac-
tors were examined.
Methods
Participants
This study was a secondary analysis in a subset of a previously described study sample [18].
Individuals aged 18–35 with different phenotypic liability to psychosis were included: (1.) 40
patients with a first diagnosis of any psychotic disorder—except for substance-induced psy-
chotic disorder and psychotic disorder due to a medical condition—established within the last
five years and (2.) 13 Patients at Ultra-High Risk (UHR) for psychosis (3.) 31 unaffected sib-
lings of patients diagnosed with a psychotic disorder and (4.) 41 healthy controls. Patients and
siblings were recruited from psychiatric institutions in The Hague, Rotterdam, Delft and Cas-
tricum in the Netherlands. UHR patients were recruited from the patient population of the
Early Detection and Intervention Team (EDIT) implemented in these institutions. Details of
the screening methodology of EDIT are described elsewhere [21]. Briefly, all referrals to sec-
ondary mental healthcare facilities were pre-screened using the self-report Prodromal Ques-
tionnaire [22]. Those scoring above the cut-off score for subclinical positive psychosis
symptoms were further assessed in a semi-structured clinical interview using the Comprehen-
sive Assessment of At-Risk Mental States (CAARMS) [23] to determine presence, severity, fre-
quency and distress of UHR symptoms. Criteria for UHR are based on the positive symptoms
subscale (including unusual thought content, non-bizarre ideas, perceptual abnormalities and
disorganized speech). The UHR patients included in this study all had both subclinical psy-
chotic symptoms as determined by the CAARMS as well as a decline in social functioning as
determined by the Social and Occupational Functioning Assessment Scale (SOFAS) [24].
Controls were recruited from the same communities through flyers in public facilities,
including schools for vocational education and dentistry practices. Exclusion criteria were
poor command of the Dutch language, an IQ lower than 75 and a history of epilepsy or auto-
immune disorder. Psychosis patients and UHR patients were classified as high psychosis liabil-
ity and siblings and healthy controls were classified as low psychosis liability, based on (1.)
phenotype of (subsyndromal) psychotic symptoms which was present in UHR and psychosis
patients and absent in siblings and healthy controls and (2.) life time risk for psychosis, which
is 100% in psychosis patients, 36% in UHR patients [25], 10% in siblings and 3% in controls
from the general population [26]. The study was approved by the medical ethical committee of
Leiden University Medical Centre. Participants received verbal and written information about
the study and were given the opportunity to ask questions to the study or an independent
researcher. At the start of experiments researchers repeated their explanation and made sure
the participants understood all procedures, before written informed consent was obtained
from all participants.
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Questionnaires
Electronic self-report questionnaires were administrated to obtain information about medical
history, length, weight, use of psychotropic and other (including over-the-counter) medica-
tion, substance use (smoking, alcohol, cannabis/THC and illicit drugs) and sociodemographic
characteristics including sex, age, ethnicity and education level. Childhood trauma was
assessed retrospectively with the Childhood Trauma Questionnaire Short Form (CTQ-SF), a
well validated 25-item self-report questionnaire including five subscales: emotional abuse,
emotional neglect, physical abuse, physical neglect and sexual abuse[27]. Childhood trauma
was defined as present if any subscale scores was classified as moderate or severe according to
published norm scores [28].
Serum measures
Blood samples were taken before questionnaires and collected in clotting tubes (5 ml) for
serum preparation. Serum samples were stored in liquid nitrogen to enable testing patient and
control immune cells in the same experiment. IFN-y and TNF-α were measured using high
sensitive ELISA kits (eBioscience) according to the manufacturer’s instructions. Briefly, stock
sera were defrosted at 4 ºC. Pre-manufactured microwells absorbed with IFN-γ coating anti-
body or TNF-α coating antibody were incubated with 50 μl of sample (diluted 2-fold) and
50 μl Biotin-conjugated anti-human TNF-α antibody or anti-human IFN-γ antibody at room
temperature on a microplate shaker. Microwells were washed and subsequently incubated
with Streptavidin-HRP. After washing, amplification agent 1 (Biotinyl-Tyramide) was added
and washed away after 15 minutes. Amplification reagent II (streptavidin-HRP) was added
and washed away after 30 minutes. Finally, the wells were incubated with substrate solution
and the reaction was terminated by addition of 1 M Posphoric acid. Absorbance was measured
at 450 nm as the primary wave length and 620 nm as reference wave length. Each plate con-
tained samples from all liability groups, a low and a high control and 7 human standard dilu-
tions, all performed in duplicate. A standard curve was prepared using a 5-parameter curve fit.
For IFN-y, 16 samples above detection limit were diluted 1:6 and repeated.
A premixed multi analyte Luminex kit (LXSAHM, R&D) was used to measure BDNF,
CCL-2, PDGF-BB and SCF. In short, 50 μl of sample (diluted 2-fold) or standard was incu-
bated with microparticle cocktail (color-coded magnetic microparticles pre-coated with ana-
lyte specific antibodies) at room temperature on a microplate shaker. Any unbound
substances were washed away using a magnetic plate washer (BioPlex, Bio-Rad). Microwells
were subsequently incubated with a biotinylated antibody cocktail specific to the analytes,
washed and incubated with streptavidin-phycoerythrin conjugate. After a final wash, the
microparticles were resuspended in buffer and read on a Luminex MAGPIX Analyzer (Bio-
Rad). Each plate contained one sample from participants from all liability groups and 6 stan-
dard dilutions performed in duplicate.
IGFBP-2 was measured using an ELISA-quantikine (R&D) according to the manufacturer’s
instructions. Sample and standard dilutions were assayed in duplicate. Participants with CRP
levels above 10 ug/ml and were excluded from analysis as this may be indicative of acute infec-
tions. This was the case for eight participants (2 healthy controls, 2 siblings, 2 UHR patients
and 2 psychosis patients).
Range and sensitivity of assays is shown in Table 1. The lowest point of each calibration
curve was considered the lower limit of quantification (LLOQ) and the highest point of each
calibration curve the upper limit of quantification (ULOQ). Number of values outside limits of
quantification are shown in Table 1. Where extrapolated values were available, these were
used. Values below the lower limit of detection were imputed with values representing 0.5
Psychosis, childhood trauma and inflammation
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times the lowest (extrapolated) value. Values above the upper limit of detection were imputed
with value 1.5x the highest (extrapolated) value.
For three samples (1 healthy control and 2 psychosis patients), there was insufficient mate-
rial to perform all assays.
Statistics
All analyses were conducted with IBM SPSS version 23. Significance was assumed at α< 0.05
(two-tailed). Continuous variables were inspected for normal distribution and log transformed
(ln) to achieve a normal distribution if necessary. Sociodemographic characteristics and serum
factor levels of cytokines and growth factors were compared between the four groups using
one-way analysis of variance (ANOVA) with three predetermined contrasts (high vs. low lia-
bility, psychosis vs. UHR and siblings vs. controls) and explorative post-hoc Dunnett’s t-tests
for continuous variables and χ2 tests for categorical variables.
We used linear or logistic regression models to examine (interaction) effects of psychosis
liability and childhood trauma. We explored association of covariates (age, sex, ln(BMI),
smoking, cannabis/THC use, ethnicity, education and use of contraceptive or other relevant
medication) with outcome measures by entering them separately in MANOVAs. Covariates
with associations with outcome measures at significant or trend level (p< 0.1) were selected
for correction of regression models. The basic model included only covariates. Subsequently,
psychosis liability was added. Next, childhood trauma was added. Lastly, the interaction term
psychosis liability x childhood trauma was added. For significant results, we subsequently
added psychotropic medication.
Results
Sociodemographic characteristics
After exclusion of participants with CRP values above 10 μg/ml, data was available for 39
healthy controls, 29 siblings, 11 ultra-high risk (UHR) and 38 psychosis patients. Sociodemo-
graphic characteristics are shown in Table 2. Groups differed significantly on gender, smoking,
education level and use of psychotropic medication. Psychosis patients were significantly more
likely to be male (χ2 (1) = 12.24, p<0.001) than healthy controls. UHR patients were
Table 1. Assay sensitivity.
BDNF CCL2 CRP IFN-y IGFBP-2 IL-6 PDGF SCF TNF-α
Technique Luminex Luminex hsELISA hsELISA ELISA hsELISA Luminex Luminex hsELISA
Range of quantification 36.4–26500
pg/ml
65.34–15880
pg/ml
0.4–10
μg/ml
0.31–20
pg/ml
15.5–1000
ng/ml
0.78–5
pg/ml
44.04–10700
pg/ml
102.88–25000
pg/ml
0.62–40 pg/
ml
N 116 115 117 117 114 117 115 115 117
Within limits of detection N
(%)
116 (100) 115 (100) 115
(98.2)
84
(71.8)
114 (100) 115
(98.2)
111 (96.5) 115 (100) 83 (70.9)
Below LLOD (N) 0 0 2 28 0 0 0 0 34
Above ULOD (N) 0 0 n.a. 5 0 2 4 0 0
Within limits of
quantification N (%)
108 (93.1) 115 (100) 90 (76.9) 56
(47.8)
114 (100) 54 (46.2) 86 (74.8) 36 (31.3) 29 (24.8)
Below LLOQ (N) 0 0 25 22 0 54 0 79 54
Above ULOQ (N) 8 0 n.a. 6 0 5 25 0 0
LLOD = lower limit of detection, ULOD = upper limit of detection LLOQ = lower limit of quantification, ULOQ = upper limit of quantification. Participants with CRP
levels above 10 ug/ml were excluded from analysis.
https://doi.org/10.1371/journal.pone.0219139.t001
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significantly more likely to smoke than healthy controls (χ2 (1) = 11.07, p = 0.001) and there
was a trend for psychosis patients to smoke more often than healthy controls (χ2 (1) = 3.649,
p = 0.056). Both UHR and psychosis patients had on average finished lower levels of education
than healthy controls (τB = -2.77, p = 0.048 and τB = -0.286, p = 0.004 for UHR and psychosis
patients, respectively). As expected, both UHR and psychosis patients were also significantly
more likely to use psychotropic medication compared to healthy controls (χ2 (1) = 28.86, p
<0.001 and χ2 (1) = 40.29, p<0.001 for UHR and psychosis patients, respectively). For none
of the UHR patients this included an antipsychotic. The sample included 12 psychosis patients
that did not use psychotropic medication.
Serum measures
Serum levels of BDNF, CCL-2, CRP, IFN-γ, IGFBP-2, IL-6, PDGF, SCF, TNF-α in controls,
siblings, UHR and psychosis patients with and without childhood trauma are depicted in Fig
1. Differences in serum levels between controls, siblings, UHR and psychosis patients were
explored with uncorrected one way analysis of variance (ANOVA). No significant group dif-
ferences were found in serum levels of BDNF, CCL-2, CRP, IFN-γ, IGFBP-2, IL-6, PDGF,
SCF, TNF-α (Table 3). Results of predetermined contrasts (high vs. low liability, psychosis vs.
UHR and siblings vs. controls) and explorative post-hoc Dunnett’s t-tests are available in sup-
plemental data.
Childhood trauma
Childhood trauma was reported by 17.9% of controls, 13.8% of siblings, 81.8% of UHR and
52.6% of psychosis patients. Both UHR and psychosis patients reported childhood trauma
Table 2. Sociodemographic characteristics.
Low psychosis liability High psychosis liability
Controls Siblings UHR Psychosis
N = 39 N = 29 N = 11 N = 38 p
Male 18 (46.2) 17 (58.6) 5 (45.5) 32 (84.2) 0.004
Age 24.0
(21.0–26.0)
25.5
(21.3–30.0)
24.0
(20.0–29.0)
25.5
(23.0–30.0)
0.438
BMI 22.8
(20.2–24.6)
23.6
(21.0–24.8)
23.1
(18.5–26.2)
23.0
(20.4–24.3)
0.979
Native Dutch 29 (74.4) 19 (67.9) 8 (72.7) 21 (55.3) 0.328
Education
No/primary 0 (0) 0 (0) 0 (0) 3 (7.9) 0.002
Vocational 10 (25.6) 9 (32.1) 7 (63.6) 17 (44.7)
Secondary 8 (20.5) 2 (7.1) 1 (9.1) 7 (18.4)
Higher 21 (53.8) 17 (60.7) 3 (27.3) 11 (28.9)
Smoking 6 (23.1) 7 (29.2) 9 (81.8) 16 (47.1) 0.005
Cannabis use 8 (20.5) 2 (7.1) 4 (36.4) 10 (26.3) 0.138
Medication
Psychotropic 0 (0) 1 (3.6) 7 (63.6) 26 (68.4) <0.001
Contraceptivea 12 (57.1) 3 (27.3) 4 (66.7) 1 (16.7)
Other 3 (7.7) 1 (3.6) 1 (9.1) 5 (13.2) 0.584
Values displayed are median (interquartile range) or N (%). P-values of ANOVA (for continuous variables), X2 tests (for dichotomous variables) or Kendall’s tau-B (for
education) are given. BMI = body mass index. Smoking during last 24 hours. Cannabis use during last month.
a Percentage of all females within group.
https://doi.org/10.1371/journal.pone.0219139.t002
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significantly more often than healthy controls (χ2 (1) = 16.09, p<0.001 and χ2 (1) = 10.17,
p = 0.001 for UHR and psychosis patients, respectively). Type and number of traumas are
depicted in Fig 2. All types of trauma were more likely to be reported by high liability group
(UHR and psychosis patients) compared to the low liability group (healthy controls and sib-
lings). These differences were significant for emotional abuse (χ2 (1) = 13.94, p< 0.001), phys-
ical abuse (χ2 (1) = 8.70, p = 0.003), sexual abuse (χ2 (1) = 5.77, p = 0.016) and emotional
neglect (χ2 (1) = 19.97, p< 0.001) and at trend level for physical neglect (χ2 (1) = 3.11,
p = 0.078).
Psychosis liability x childhood trauma
Separate and interaction effects of psychosis liability and childhood trauma on serum levels
were examined using linear regression models. Sex, age, BMI, smoking, cannabis use,
Fig 1. Serum levels of cytokines and growth factors in healthy controls, siblings, UHR and psychosis patients. Out of range concentrations on the lower or upper
end of detection were imputed with values representing 0.5 times the lowest value or 1.5 times the highest value, respectively.
https://doi.org/10.1371/journal.pone.0219139.g001
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education and oral contraceptive use were selected as covariates, as they were associated with
outcome measures in MANOVA significantly or at trend level (p< 0.10). Regression coeffi-
cients of corrected models are shown in Table 4. Regression coefficients of uncorrected models
and models with additional correction for psychotropic use are available in supplemental data.
Addition of group, childhood trauma or the interaction term did not significantly improve the
model for any of the cytokines and growth factors. There were no significant or trend level
main or interaction effects of psychosis liability or trauma on growth factors and cytokines.
Discussion
We examined separate and interaction effects of psychosis liability and childhood trauma on
serum levels of cytokines and growth factors. No statistically significant effects of psychosis lia-
bility or childhood trauma on concentrations of cytokines or growth factors in peripheral
blood were found, nor were there any statistically significant interaction effects of psychosis
liability with childhood trauma on serum levels of cytokines and growth factors.
It is possible that the sample size in our study was too small to reach statistically signifi-
cance. Furthermore, selection bias cannot be ruled and could have resulted in a relatively
healthy patient population. The disease trajectories of the recent onset psychosis patients in
this sample are still unknown, some will completely recover and not experience any other psy-
chotic episodes, whereas others will develop a more chronic debilitating pattern of disease. A
large proportion was taking antipsychotic medication and many may have been (partly) in
remission. Similarly, a large portion of the UHR sample will develop a full-blown psychotic
episode, whereas in others, the psychotic-like symptoms will lessen and/or functioning will
improve. Thus, homeostasis may still be maintained or already restored in our sample.
Confounding factors may also explain differences between our negative results and previ-
ous findings. BMI, sex and age are known to affect cytokine levels in peripheral blood [29–31]
and were indeed associated with outcome measures in our sample. Especially obesity is consid-
ered a likely confounder in psychosis studies, as it is linked with inflammatory markers, more
common among psychosis patients and further increased by the use of psychotropic medica-
tion use [32,33]. We corrected for BMI, sex and age in our sample. Furthermore, in contrast to
many previous studies, our sample was characterized by an on average healthy BMI, with no
statistically significant differences in BMI between groups. In the sample of Dennison et al.,
patients were considerable older, more likely to be obese and all used psychotropic medication,
Table 3. ANOVA test statistics.
F df p η2
Ln(BDNF) 1.296 3, 112 0.279 0.034
Ln(CCL-2) 0.652 3, 111 0.583 0.017
Ln(CRP) 0.673 3, 113 0.570 0.018
Ln(IFN-γ) 0.318 3, 113 0.813 0.008
Ln(IGFBP-2) 1.435 3, 110 0.237 0.038
Ln(IL-6) 0.290 3, 113 0.832 0.008
Ln(PDGF) 0.264 3, 111 0.851 0.007
Ln(SCF) 0.690 3, 111 0.560 0.018
Ln(TNF-α) 0.924 3, 113 0.432 0.024
Four psychosis liability groups (healthy controls, unaffected siblings, UHR patients and psychosis patients) were
tested using one-way analysis of variance. η2 = partial eta squared effect size (0.01–0.06: small effect, 0.06–0.014:
moderate effect > 0.14: large effect).
https://doi.org/10.1371/journal.pone.0219139.t003
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often a combination of multiple agents [16]. Hepgul et al. studied first-episode psychosis
patients and found CRP levels to be increased in the subset of patients who were traumatized,
specifically by the experience of sexual abuse [17]. Even these first-episode psychosis patients
had significantly higher BMI than controls. Moreover, BMI was associated with both sexual
abuse and CRP levels and thus could have confounded results. In a recent study examining the
influence of BMI on cytokines in drug naive first-episode psychosis patients, IL-8 was the only
cytokine increased in normal-weight patients compared to normal-weight controls [34],
whereas over-weight patients had increased levels of IL-6, IL-8, CCL-4, IL-13, IL-2, IL-7, IL-
12p70 and IL-23 compared to over-weight controls [34]. Interestingly, there was no difference
Fig 2. Childhood trauma as reported by groups with different psychosis liability. The Childhood Trauma
Questionnaire (CTQ) was used to assess different types of abuse and neglect retrospectively. Percentages of
participants within each group that reported moderate or severe levels of emotional abuse, physical abuse, sexual
abuse, emotional neglect and physical neglect are shown.
https://doi.org/10.1371/journal.pone.0219139.g002
Table 4. Regression coefficients.
Psychosis liability Childhood trauma Psychosis liability x childhood trauma
B [CI] p B [CI] p B [CI] p
BDNF -0.02 [-0.18; 0.15] 0.837 -0.02 [-0.23; 0.19] 0.875 0.02 [-0.24; 0.29] 0.860
CCL-2 -0.17 [-0.41; 0.08] 0.179 0.00 [-0.31; 0.31] 0.979 0.08 [-0.32; 0.48] 0.689
CRP 0.07 [-0.56; 0.71] 0.819 0.02 [-0.81; 0.85] 0.960 0.11 [-0.94; 1.16] 0.838
IFN-γ 0.14 [-0.11; 0.40] 0.258 0.20 [-0.11; 0.51] 0.195 -0.28 [-0.68; 0.12] 0.163
IGFBP-2 0.47 [-0.21; 1.16] 0.172 -0.23 [-1.12; 0.66] 0.603 -0.38 [-1.51; 0.74] 0.500
IL-6 0.02 [-1.40; 1.44] 0.981 -1.14 [-2.99; 0.71] 0.224 1.16 [-1.18; 3.51] 0.327
PDGF 0.07 [-0.18; 0.32] 0.587 0.20 [-0.12; 0.52] 0.218 -0.37 [-0.78; 0.04] 0.073
SCF -0.11 [-0.34; 0.11] 0.321 0.09 [-0.20; 0.37] 0.540 -0.01 [-0.38; 0.35] 0.943
TNF-α 0.39 [-0.45; 1.23] 0.360 -0.75 [-1.84; 0.35] 0.179 0.73 [-0.66; 2.12] 0.297
Regression coefficients of linear regression models are given. Models included psychosis liability (high vs. low), childhood trauma (yes/no) and psychosis liability x
childhood trauma as predictors and were corrected for sex, age, BMI, smoking, cannabis use, education and oral contraceptive use.
https://doi.org/10.1371/journal.pone.0219139.t004
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between over- and normal-weight controls, whereas overweight patients had increased con-
centrations of inflammatory markers compared to normal-weight patients. While no formal
interaction test was performed in this study, these findings are suggestive of an interaction
effect between obesity and psychosis liability. Such an interaction effect would explain the neg-
ative results of our study where psychosis liability was present, but obesity relatively rare.
Thus, obesity may be an essential player in the complex relation between psychosis, metabolic
syndrome and immune dysregulation rather than a simple confounding factor.
Patients with psychotic disorders, including this study sample, form a heterogenous group
and previous work has shown the course of immune dysregulation in psychosis patients to be
highly dynamic, involving both pro- and anti-inflammatory forces. Cytokines and growth fac-
tors in peripheral blood are the end-product of diverse processes and players, including non-
immune cells, e.g. adipocytes and endothelial cells. Immune dysregulation may occur without
affecting serum cytokine levels, especially as pro-inflammatory mechanisms may be—tempo-
rarily—compensated by an increased anti-inflammatory response.
Limitations
Childhood trauma was measured retrospectively, which has the potential for recall bias. We
used the Childhood Trauma Questionnaire, which is considered a well-validated and reliable
instrument [27,35]. Furthermore, retrospective report of childhood trauma by psychosis
patients was shown to be reliable [36]. We previously reported on the increased prevalence of
childhood trauma in patients with high psychosis liability in this sample and found that
patients with a history of childhood trauma reported more psychotic and affective symptoms
in daily life and more paranoid ideation and stress after exposure to social stress in a virtual
reality environment [37]. Our findings are in line with previous research, finding a high preva-
lence of childhood trauma in UHR [38] and psychosis patients [11] and increased prevalence
of childhood trauma in psychosis patients compared to unaffected siblings [39]. In this second-
ary analysis, we confirmed increased prevalence of childhood trauma in UHR and psychosis
patients in this subset and show that all subtypes of traumas had an increased prevalence, with
a trend level effect for physical abuse and statistically significant effects for all other subtypes.
We selected four group along the psychosis liability spectrum. While psychosis liability is a
continuous concept, we dichotomized it into lower and higher liability to analyse (interaction)
effects of childhood trauma. The sample size was too small to analyse groups separately, espe-
cially as childhood trauma was extremely common among UHR, limiting the number of UHR
patients without childhood trauma. We considered classifying siblings and UHR patients as an
intermediate risk group, but as siblings were more comparable to controls both in terms of life
time psychosis risk and phenotype, we considered it more valid to classify controls and siblings
as lower and UHR and psychosis patients as higher psychosis liability groups. The life time
risk of psychotic disorders is approximately 3% for controls (general population), 10% for sib-
lings[26], 36% for UHR [25] and, by definition, 100% for patients with recent onset psychotic
disorder. UHR and psychosis patients all reported (subsyndromal) psychotic symptoms,
which were uncommon among siblings and controls from the general population.
We used high sensitive assays. Still, some values were outside the limit of detection, either
being undetectably low or out of range high. Furthermore, a larger proportion of values were
extrapolated by software as they were outside the calibration curve. The latter proportions
were especially high for IFN-γ, IL-6, SCF and TNF-α (Table 1). The reliability of these mea-
surements may be decreased by increased measurement error. However, they are not invalid
measurements and still confer meaning and we therefore included them in our analysis. We
aimed to be detailed and transparent regarding assay sensitivity and data reliability, but were
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unable to compare the sensitivity of our assays to other studies as the information reported
was very limited.
Conclusions
We did not find evidence for independent or interaction effect of psychosis liability or child-
hood trauma on peripheral levels of cytokines and growth factors in this sample. These nega-
tive results should be interpreted within a framework of meta-analytic work showing immune
deregulation in psychosis—which is known to be highly dynamic, the heterogeneity of patients
with psychotic disorders and signs for a complex interaction with obesity.
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